Resources

Showing 62 Results

Pharmacists Can Help the Pharmaceutical Ecosystem Work Better for Patients

In a commentary, NPC President and CEO John O’Brien reflects on his personal experience as a pharmacist and how that training led him on the path to a career in health policy.

JMCP Article on Cost Sharing and Adherence

Cost-Sharing and Adherence, Clinical Outcomes, Health Care Utilization, and Costs: A Systematic Literature Review

Higher patient cost-sharing for prescription medications leads to worse medication initiation, adherence, persistence, and discontinuation, according to a new systematic literature review by…

High Patient Out-of-Pocket Costs Lead to Worse Medication Adherence Without Overall Health Care Savings

Research from NPC and Xcenda suggests that high cost-sharing for prescription medications may have negative effects on patient health while not actually decreasing overall health care costs.

Pharmacist helping patient at a counter.

Why Patients Are Paying More at the Pharmacy Counter in Early 2022 - And What We Can Do to Fix It

NPC Immediate Past Board Chair Mike Ryan and CSO Sharon Phares explore policy solutions to ensure patients can have predictable and affordable out-of-pocket costs for medicines.

Pharmacist talking to patient, wearing masks

Drug Price Controls in Medicare Part D: Not a Remedy for More Than 5 Million Medicare Beneficiaries

Proposals seeking to improve access for Medicare beneficiaries should ensure that patients are better able to get the medicines their doctors say they need.

Prevalence of Avoidable and Bias-Inflicting Methodological Pitfalls in Real-World Studies of Medication Safety and Effectiveness

This paper focuses on recognizing methodological flaws in RWE studies so that researchers can avoid these flaws by identifying them ahead of time – not just after a study is complete.

Avoiding Methodological Faults in Real-World Evidence

Researchers from Brigham and Women’s Hospital, Harvard Medical Center and NPC found that the potential for biased findings in RWE studies increases substantially in the absence of a rigorous and…

Walking the Walk: Taking Needed Steps to Reduce Low-Value Care

Three leading researchers detail steps to reduce low-value care in the latest edition of The American Journal of Managed Care. Their approach complements a similar effort, the Roadmap for Addressing…

The Impact of COVID-19 on Real-World Health Data and Research

This white paper provides key health care stakeholders, including clinicians, researchers, payers and regulators, with a broad view of how the COVID-19 pandemic may have impacted real-world data (RWD…

What’s In Your RWE Evaluation Toolbox?

Real-world evidence (RWE) – information collected from everyday health care experiences – is growing in availability, and many health care decision-makers are interested in understanding and using…

Online Tools to Synthesize Real-World Evidence of Comparative Effectiveness Research to Enhance Formulary Decision Making

The authors describe and compare the features and characteristics of five tools to evaluate real-world evidence studies and add clarity on what the tools provide.

Empowering the Patient Voice in Value Assessment: Paving the Way for MCDA

The National Health Council (NHC) and National Pharmaceutical Council (NPC) co-hosted a webinar that explored how multi-criteria decision-making analysis (MCDA) can be used in value assessment.

Multi-Criteria Decision Analysis: A Way to Put Patient Concerns Front and Center in Value Assessment?

NHC and NPC released a white paper outlining multi-criteria decision analysis (MCDA), an approach to value assessment that may more holistically address patients’ concerns, experiences and treatment…

Multi-Criteria Decision Analysis: Can It Help Make Value Assessment More Patient Centered?

This white paper identifies good practices and key considerations for integrating the patient voice into patient-centered multi-criteria decision analysis.

NPC Comments on PCORI's Proposed Principles for the Consideration of the Full Range of Outcomes Data

NPC offered public feedback to PCORI on its new mandate to consider the full range of patient-centered outcomes in its research.

Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How Recommendations and a Roadmap from the Real-World Evidence Transparency Initiative

A position paper by the RWE Transparency Initiative describes a plan for improving the transparency of the research process and making registration of real-world evidence study methods easier and…

Filter by: